M. Fournier

发表

Chemical synthesis, characterisation and biological evaluation of lactonic-estradiol derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 1

D. Poirier, S. Farhane, M. Fournier, 2013, The Journal of Steroid Biochemistry and Molecular Biology.

Convergent stereoselective and efficient synthesis of furanic-steroid derivatives

D. Poirier, S. Farhane, M. Fournier, 2011 .

Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.

D. Poirier, M. Fournier, C. Cadot, 2008, Bioorganic & medicinal chemistry.

Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.

V. Parissi, M. Andreola, M. Fournier, 2002, Current pharmaceutical design.

Interaction of tRNA-derivatives and oligonucleotide primers with AZT-resistant mutants of HIV-1 reverse transcriptase.

S. Kochetkov, S. Gudima, M. Fournier, 1998, Bioorganic & medicinal chemistry.

Functional Interactions of Human Immunodeficiency Virus Type 1 Integrase with Human and Yeast HSP60

C. Calmels, V. Parissi, A. Caumont, 2001, Journal of Virology.

Biochemical and random mutagenesis analysis of the region carrying the catalytic E152 amino acid of HIV-1 integrase.

C. Calmels, V. Parissi, A. Caumont, 2004, Nucleic acids research.

Photochemical cross-linking studies on the interactions of avian myeloblastosis virus reverse transcriptase with primer tRNATrp and TTP.

G. Keith, M. Fournier, S. Litvak, 1980, Archives of biochemistry and biophysics.

Inhibition of the p66/p51 form of human immunodeficiency virus reverse transcriptase by tRNA(Lys).

P. Barr, B. Bordier, M. Fournier, 1990, Nucleic acids research.

Interactions with tRNA(Lys) induce important structural changes in human immunodeficiency virus reverse transcriptase.

P. Barr, B. Bordier, M. Fournier, 1990, FEBS letters.

The lethal phenotype observed after HIV-1 integrase expression in yeast cells is related to DNA repair and recombination events.

C. Calmels, V. Parissi, M. Bonneu, 2003, Gene.

Priming of HIV replication by tRNA(Lys3): role of reverse transcriptase.

M. Andreola, M. Fournier, L. Tarrago-Litvak, 1994, Trends in biochemical sciences.

High affinity interaction of HIV‐1 integrase with specific and non‐specific single‐stranded short oligonucleotides

V. Parissi, G. Nevinsky, A. Caumont, 1999, FEBS Letters.

Structural constraints in the HIV-1 reverse transcriptase-primer/template complex for the initiation of DNA synthesis from primer tRNALys3.

M. Andreola, M. Fournier, L. Tarrago-Litvak, 1998, Biochemistry.

DNA synthesis primed by mononucleotides (de novo synthesis) catalyzed by HIV‐1 reverse transcriptase: tRNALys,3 activation

M. Fournier, L. Tarrago-Litvak, S. Litvak, 1995, FEBS letters.

Interaction of primer tRNALys3 with the p51 subunit of human immunodeficiency virus type 1 reverse transcriptase: a possible role in enzyme activation

M. Andreola, M. Fournier, L. Tarrago-Litvak, 1995, FEBS letters.

Interaction of tRNALys with the p66/p66 form of HIV-1 reverse transcriptase stimulates DNA polymerase and ribonuclease H activities.

P. Barr, M. Andreola, B. Bordier, 1992, Journal of Biological Chemistry.

Human immunodeficiency virus reverse transcriptase expressed in transformed yeast cells. Biochemical properties and interactions with bovine tRNALys.

P. Barr, M. Fournier, L. Tarrago-Litvak, 1989, European journal of biochemistry.

Interaction of human immunodeficiency virus type 1 reverse transcriptase with primer tRNALys3 and affinity modification of the enzyme by tRNALys3 derivatives.

M. Andreola, M. Fournier, L. Tarrago-Litvak, 1996, European journal of biochemistry.

Interactions with tRNALys induce important structural changes in human immunodeficiency virus reverse transcriptase

P. Barr, B. Bordier, M. Fournier, 1990 .

p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.

M. Andreola, M. Fournier, L. Tarrago-Litvak, 1998, European journal of biochemistry.

Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase.

Simon Litvak, V. Parissi, M. Fournier, 2004, Biochemistry.

HIV-1 integrase interacts with yeast microtubule-associated proteins.

E. Bon, P. Durrens, C. Calmels, 2002, Biochimica et biophysica acta.

Chromosomal integration of LTR-flanked DNA in yeast expressing HIV-1 integrase: down regulation by RAD51

P. Sung, C. Calmels, V. Parissi, 2006, Nucleic acids research.

Estrogen formation in endometrial and cervix cancer cell lines: Involvement of aromatase, steroid sulfatase and 17β-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12)

D. Poirier, M. Fournier, 2009, Molecular and Cellular Endocrinology.

Enzymatic conversion of adenosine to inosine in the wobble position of yeast tRNAAsp: the dependence on the anticodon sequence.

H. Grosjean, M. Fournier, S. Henau, 1984, Nucleic acids research.

Development of 3-substituted-androsterone derivatives as potent inhibitors of 17β-hydroxysteroid dehydrogenase type 3.

D. Poirier, M. Fournier, R. Maltais, 2011, Bioorganic & medicinal chemistry.

Enzymatic conversion of adenosine to inosine and to N1-methylinosine in transfer RNAs: a review.

S. Auxilien, C. Simon, H. Grosjean, 1996, Biochimie.

HIV-1 integrase and RNase H activities as therapeutic targets

V. Parissi, M. Andreola, M. Fournier, 2002, Expert opinion on therapeutic targets.

HIV‐1 integrase trafficking in S. cerevisiae: a useful model to dissect the microtubule network involvement of viral protein nuclear import

B. Salin, C. Calmels, V. Parissi, 2009, Yeast.

A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.

B. Roques, N. Morellet, C. Lenoir, 2002, Journal of molecular biology.

Chemical Synthesis, 17β-Hydroxysteroid Dehydrogenase Type 1 Inhibitory Activity and Assessment of In Vitro and In Vivo Estrogenic Activities of Estradiol Derivatives

D. Poirier, M. Fournier, François Rouillard, 2008 .

Myelin P0 Glycoprotein: Identification of the Site Phosphorylated In Vitro and In Vivo by Endogenous Protein Kinases

M. Fournier, J. Bonnet, J. Gandar, 1995, Journal of neurochemistry.

Site‐directed in vitro replacement of nucleosides in the anticodon loop of tRNA: application to the study of structural requirements for queuine insertase activity.

P. Carbon, H. Grosjean, M. Fournier, 1983, The EMBO journal.

Involvement of tRNA in retrovirus expression: biological implications of reverse transcriptase-primer tRNA interactions.

M. Fournier, S. Litvak, A. Araya, 1983, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

tRNATrp (bovine) binding to the reverse transcriptase of avian myeloblastosis virus and function as a heterologous primer.

J. G. Chirikjian, T. Papas, M. Fournier, 1977, Proceedings of the National Academy of Sciences of the United States of America.

Reprint of “In vitro and in vivo evaluation of a 3β-androsterone derivative as inhibitor of 17β-hydroxysteroid dehydrogenase type 3”

D. Poirier, J. Roy, M. Fournier, 2014, The Journal of Steroid Biochemistry and Molecular Biology.

In vitro and in vivo evaluation of a 3β-androsterone derivative as inhibitor of 17β-hydroxysteroid dehydrogenase type 3

D. Poirier, J. Roy, M. Fournier, 2014, The Journal of Steroid Biochemistry and Molecular Biology.